role of vacuum constriction devices in the treatment of erectile dysfunction: a comparative study with intracorporeal pharmacotherapy

A total of 77 impotent patients went through complete history, physical examination, hormonal assay, Doppler examination, cavernosometry and intracorporeal papaverine test followed by division into group [a] [47 patients], who used vacuum constriction device and group [b] [30 patients], who used the intracorporeal pharmacotherapy. During the 7 months of follow up satisfactory response occurred in 33 patients of group [a] [70.2%] and in 20 patients of group [b] [66.6%]. No serious side effects were reported. This study emphasizes on the important role of non-surgical treatment of impotence that may obviate the need for more invasive investigations or unnecessary surgical intervention in many patients